Karun Kumar Kunden

Karun Kumar Kunden

Active Director Whole-Time Director DIN 08384169
DIN 08384169 First appointment Apr 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Karun Kumar Kunden

Data last updated:

Karun Kumar Kunden is a Whole-Time Director at Diers Biomedical Solutions Private Limited (since 2019). The company operates in Pharma. Diers Biomedical Solutions Private Limited reported revenue of ₹3.28 Cr (FY 2024).

DIN 08384169
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 01 Apr 2019
Oldest Company Age 14 yrs
Largest company Diers Biomedical Solutions Private Limited · ₹3.28 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director01 Apr 20192012₹3.28 Cr (FY 2024)Active

Board colleagues of Karun Kumar Kunden

Directorship timeline

Open interactive timeline →
Diers Biomedical Solutions Private Limited
Premium access

Shareholding and investment profile for Karun Kumar Kunden

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karun Kumar Kunden

Karun Kumar Kunden currently holds 1 directorship: Diers Biomedical Solutions Private Limited (Whole-Time Director, since 01 Apr 2019, revenue ₹3.28 Cr (FY 2024)).

Karun Kumar Kunden was first appointed on 01 Apr 2019 as Whole-Time Director at Diers Biomedical Solutions Private Limited.

The current boards of Karun Kumar Kunden's companies include Carsten Helmut Diers (Diers Biomedical Solutions Private Limited), Loretta Maria Zircher (Diers Biomedical Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available